Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone Mass
Clinical trial NCT01604057 · UNKNOWN
Trial details
- NCT number
- NCT01604057
- Sponsor
- Azelon Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2012-07-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.